𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatic iron and nonalcoholic fatty liver disease

✍ Scribed by Zobair M. Younossi; Terry Gramlich; Bruce R. Bacon; Christi A. Matteoni; Navdeep Boparai; Rosemary O'Neill; Arthur J. McCullough


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
97 KB
Volume
30
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Relationship between the pattern of hepa
✍ James E. Nelson; Laura Wilson; Elizabeth M. Brunt; Matthew M. Yeh; David E. Klei πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 301 KB πŸ‘ 2 views

Previous studies examining the relationship between hepatic iron deposition and histological severity in nonalcoholic fatty liver disease (NAFLD) have been inconclusive. The goal of this study was to examine the relationship between hepatic iron deposition and liver histology in 849 patients enrolle

Iron and fibrosis in nonalcoholic fatty
✍ Graeme A. Macdonald; Patrick J. Ward; D. Keith George; Lawrie W. Powell πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 29 KB πŸ‘ 2 views
Nonalcoholic fatty liver disease and liv
✍ Paul Angulo πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 229 KB

Nonalcoholic fatty liver disease affects a substantial proportion of the general population worldwide. This high prevalence of nonalcoholic fatty liver disease has important consequences in the donor selection process for liver transplantation, and in the posttransplant period given the high recurre

Nonalcoholic fatty liver disease after l
✍ Kanthi Yalamanchili; Sherif Saadeh; GΓΆran B. Klintmalm; Linda W. Jennings; Gary πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 262 KB

Nonalcoholic steatohepatitis (NASH) may account for many cases of cryptogenic cirrhosis. If so, then steatosis might recur after liver transplantation. Two thousand fifty-two patients underwent primary liver transplantation for chronic liver disease between 1986 and 2004. Serial liver biopsy samples

Valproate therapy and nonalcoholic fatty
✍ Gerhard J. Luef; Markus Waldmann; Wolfgang Sturm; Anis Naser; Eugen Trinka; Iris πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 1 views

## Abstract Nonalcoholic fatty liver disease was defined recently as another symptom of insulin resistance. Continuous therapy with valproate can result in increased body weight and insulin resistance, but no data are yet available on a possible relationship between valproate and nonalcoholic fatty